View in EDS

Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study.

Saved in:
Bibliographic Details
Title: Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study.
Authors: Klamroth R; Vivantes Klinikum, Landsberger Allee 49, 10249 Berlin, Germany.; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany., Recht M; Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA.; National Bleeding Disorders Foundation, 1230 Avenue of the Americas 16th Floor, New York, NY 10020, USA., Key NS; UNC Blood Research Center and Department of Medicine, University of North Carolina, 8008 Mary Ellen Jones Building, CB7035 Chapel Hill, NC 27514, USA., Miesbach W; Department of Haemostaseology and Haemophilia, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany., Pipe SW; Departments of Pediatrics and Pathology, University of Michigan, 1500 East Medical Drive, Ann Arbor, MI 48109-5718, USA., Kaczmarek R; Department of Pediatrics, Indiana University School of Medicine, 1044 West Walnut Street, R4-116, Indianapolis, IN 46202, USA., Drelich D; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA., Salazar B; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA., Le Quellec S; CSL Behring Europe, Philipp-Reis-Strasse 2, 65795 Hattersheim am Main, Germany., Monahan PE; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA., Galante N; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA., van der Valk P; Center for Benign Haematology, Thrombosis and Haemostasis, University Medical Center Utrecht, University Utrecht, Van Creveldkliniek, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Tarrant J; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA.
Source: Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2025 Aug 18; Vol. 33 (3), pp. 101568. Date of Electronic Publication: 2025 Aug 18 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40969675
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Klamroth+R%22">Klamroth R</searchLink>; Vivantes Klinikum, Landsberger Allee 49, 10249 Berlin, Germany.; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Recht+M%22">Recht M</searchLink>; Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA.; National Bleeding Disorders Foundation, 1230 Avenue of the Americas 16th Floor, New York, NY 10020, USA.<br /><searchLink fieldCode="AU" term="%22Key+NS%22">Key NS</searchLink>; UNC Blood Research Center and Department of Medicine, University of North Carolina, 8008 Mary Ellen Jones Building, CB7035 Chapel Hill, NC 27514, USA.<br /><searchLink fieldCode="AU" term="%22Miesbach+W%22">Miesbach W</searchLink>; Department of Haemostaseology and Haemophilia, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Pipe+SW%22">Pipe SW</searchLink>; Departments of Pediatrics and Pathology, University of Michigan, 1500 East Medical Drive, Ann Arbor, MI 48109-5718, USA.<br /><searchLink fieldCode="AU" term="%22Kaczmarek+R%22">Kaczmarek R</searchLink>; Department of Pediatrics, Indiana University School of Medicine, 1044 West Walnut Street, R4-116, Indianapolis, IN 46202, USA.<br /><searchLink fieldCode="AU" term="%22Drelich+D%22">Drelich D</searchLink>; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA.<br /><searchLink fieldCode="AU" term="%22Salazar+B%22">Salazar B</searchLink>; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA.<br /><searchLink fieldCode="AU" term="%22Le+Quellec+S%22">Le Quellec S</searchLink>; CSL Behring Europe, Philipp-Reis-Strasse 2, 65795 Hattersheim am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Monahan+PE%22">Monahan PE</searchLink>; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA.<br /><searchLink fieldCode="AU" term="%22Galante+N%22">Galante N</searchLink>; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA.<br /><searchLink fieldCode="AU" term="%22van+der+Valk+P%22">van der Valk P</searchLink>; Center for Benign Haematology, Thrombosis and Haemostasis, University Medical Center Utrecht, University Utrecht, Van Creveldkliniek, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Tarrant+J%22">Tarrant J</searchLink>; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101624857%22">Molecular therapy. Methods & clinical development</searchLink> [Mol Ther Methods Clin Dev] 2025 Aug 18; Vol. 33 (3), pp. 101568. <i>Date of Electronic Publication: </i>2025 Aug 18 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101624857 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2329-0501 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223290501%22">23290501 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Methods Clin Dev <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40969675
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omtm.2025.101568
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101568
    Titles:
      – TitleFull: Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Klamroth R
      – PersonEntity:
          Name:
            NameFull: Recht M
      – PersonEntity:
          Name:
            NameFull: Key NS
      – PersonEntity:
          Name:
            NameFull: Miesbach W
      – PersonEntity:
          Name:
            NameFull: Pipe SW
      – PersonEntity:
          Name:
            NameFull: Kaczmarek R
      – PersonEntity:
          Name:
            NameFull: Drelich D
      – PersonEntity:
          Name:
            NameFull: Salazar B
      – PersonEntity:
          Name:
            NameFull: Le Quellec S
      – PersonEntity:
          Name:
            NameFull: Monahan PE
      – PersonEntity:
          Name:
            NameFull: Galante N
      – PersonEntity:
          Name:
            NameFull: van der Valk P
      – PersonEntity:
          Name:
            NameFull: Tarrant J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 08
              Text: 2025 Aug 18
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2329-0501
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular therapy. Methods & clinical development
              Type: main
ResultId 1